Sanofi to sell 51% stake in Opella
Sanofi in exclusive talks with CD&R over sale of $17 billion Opella
By Dominique Patton PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R).
Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&R
Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare
Sanofi Sells Controlling Stake in Opella to CD&R with Job Guarantees
CD&R is nearing a deal to acquire control of Sanofi’s consumer health unit after it signed social commitments with the French government.
France considering stake in Sanofi's Opella, minister says
France is considering taking a stake in Sanofi's Opella arm, said finance minister Antoine Armand, to allay concerns that the French drugmaker's plans to sell a 50% stake in Opella to a U.S. private equity firm could result in job cuts.
Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
Sanofi entered into exclusive talks to sell a controlling stake in its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that values the business as a whole at 16 billion euros ($17.
Sanofi Enters Exclusive Talks to Sell 50% Stake in Opella to CD&R
Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered exclusive negotiations to sell a 50% controlling stake in its consumer health division,
Sanofi, CD&R in Exclusive Negotiations for Sale, Purchase of 50% Stake in Opella
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing opportunities, strengthen advisor-client relationships and build investor experiences. Learn More. Back To Top
Sanofi enters exclusive talks with CD&R for Opella sale
Sanofi said on Monday it had entered exclusive negotiations for the sale of a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton Dubilier & Rice (CD&R). The French pharmceutical company said its Opella business has been valued at around 16 billion euros ($17.
US takeover of prized French painkiller to go ahead
Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...
Sanofi pursues sale of painkiller after political controversy
Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after ...
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...
France takes stake in Sanofi as it moves ahead with CD&R deal
US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.
France 243h
Sanofi pursues sale of France's leading painkiller to US investment fund after controversy
French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...
Daily3h
Sanofi closes deal for consumer health unit Opella: Report
The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the ...
Sanofi in Talks With French Government to Address Concerns on Opella Deal
Sanofi is in discussions with the French government to address concerns officials raised about a potential sale of a ...